Gordon Dunn
Chief Financial Officer · Quoin Pharmaceuticals, Ltd.
- 2024
- Dec 27, 2024
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gordon Dunn files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dennis Langer - $129K in QNRX purchases and sales in the last 12 months
- Michael Myers - $100K in QNRX purchases and sales in the last 12 months
- Denise P. Carter - $100K in QNRX purchases and sales in the last 12 months
- Sally Bridget Lawlor - $50K in QNRX purchases and sales in the last 12 months
- Anthony James Culverwell - $30K in QNRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gordon Dunn?
Gordon Dunn is a corporate insider, tracked as Chief Financial Officer of Quoin Pharmaceuticals, Ltd. (QNRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Gordon Dunn last file a Form 4?
The most recent primary Form 4 on record is dated 27 December 2024, one of 2 filings going back to 2024.
Has Gordon Dunn been buying or selling stock?
Recorded transactions: 3 open-market purchases ($55K) and 0 open-market sales across all tracked filings.
